| Literature DB >> 26564554 |
H M Murphy1, M K Thomas1, D T Medeiros2, S McFADYEN2, K D M Pintar1.
Abstract
The estimated burden of endemic acute gastrointestinal illness (AGI) annually in Canada is 20·5 million cases. Approximately 4 million of these cases are domestically acquired and foodborne, yet the proportion of waterborne cases is unknown. A number of randomized controlled trials have been completed to estimate the influence of tap water from municipal drinking water plants on the burden of AGI. In Canada, 83% of the population (28 521 761 people) consumes tap water from municipal drinking water plants serving >1000 people. The drinking water-related AGI burden associated with the consumption of water from these systems in Canada is unknown. The objective of this research was to estimate the number of AGI cases attributable to consumption of drinking water from large municipal water supplies in Canada, using data from four household drinking water intervention trials. Canadian municipal water treatment systems were ranked into four categories based on source water type and quality, population size served, and treatment capability and barriers. The water treatment plants studied in the four household drinking water intervention trials were also ranked according to the aforementioned criteria, and the Canadian treatment plants were then scored against these criteria to develop four AGI risk groups. The proportion of illnesses attributed to distribution system events vs. source water quality/treatment failures was also estimated, to inform the focus of future intervention efforts. It is estimated that 334 966 cases (90% probability interval 183 006-501 026) of AGI per year are associated with the consumption of tap water from municipal systems that serve >1000 people in Canada. This study provides a framework for estimating the burden of waterborne illness at a national level and identifying existing knowledge gaps for future research and surveillance efforts, in Canada and abroad.Entities:
Keywords: Epidemiology; estimating disease prevalence; public health; water (quality)
Mesh:
Substances:
Year: 2015 PMID: 26564554 PMCID: PMC4823834 DOI: 10.1017/S0950268815002083
Source DB: PubMed Journal: Epidemiol Infect ISSN: 0950-2688 Impact factor: 2.451
Fig. 1.Key steps in the model development for the estimation of acute gastrointestinal illness (AGI) associated with the consumption of water from municipal water treatment systems serving >1000 people in Canada. RCT, Randomized controlled trial.
Canadian drinking water system ranking criteria and corresponding scores used for Canadian municipal systems serving >1000 people
| Criteria | Subcategories | Score |
|---|---|---|
| Source water type | Surface water | 1 |
| GUDI, mixed sources | 2 | |
| Groundwater | 3 | |
| Microbial source water quality | Pristine (⩽0·1 c.f.u. | 4 |
| Lightly impacted (>0·1 to ⩽10 c.f.u. | 3 | |
| Moderately impacted (>10 to ⩽100 c.f.u./100 ml) | 2 | |
| Highly impacted (>100 c.f.u./ 100 ml) | 1 | |
| Log reduction capability of treatment system | See | 0–6·42 |
| Treatment barriers in place | See | 0–4 |
| Population served | >10 000 | 2 |
| 1000–10 000 | 1 |
GUDI, Groundwater under the direct influence of surface water.
Municipal water treatment system categories and estimated minimum log reductions by pathogen for each treatment category (Health Canada QMRA model) as well as corresponding minimum log reduction and barrier values assigned for the ranking of drinking water systems
| Category | Treatment category details | Minimum (min) log10 reduction values/ranges for reference pathogens | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Coagulation | Filtration | Disinfection | Rotavirus | Min. log reduction | Min. barriers | |||||
| 1 | Coag/floc/sed | RG (coag/sed) | Optional chemical | 2·42 | 2·42 | 2·87 | 4·27 | 3·53 | 2·42 | 2 |
| 2 | − | RG (direct filt) | Chemical | 2·37 | 1·49 | 0·62 | 2·97 | 2·87 | 0·62 | 2 |
| 3 | − | RG (no coag)/SS or bag filt. | Chemical | 1·56 | 0·68 | 0·80 | 1·11 | 1·24 | 0·80 | 2 |
| 4 | Coag/floc/sed | MF/UF and optional RG/SS | Chemical | 7·16 | 6·28 | 2·89 | 7·99 | 7·80 | 2·89 | 3 |
| 5 | Coag/floc/sed | RG (coag/sed) | Chemical | 8·43 | 8·05 | 6·42 | 8·70 | 7·54 | 6·42 | 4 |
| 6 | − | RG (direct filt) | Chemical | 7·37 | 6·99 | 4·7 | 7·40 | 6·87 | 4·70 | 3 |
| 7 | − | RG (no coag)/SS or bag filt. | Chemical | 6·56 | 6·18 | 4·88 | 5·54 | 5·24 | 4·88 | 3 |
| 8 | Optional coag/floc/sed | MF/UF | Chemical | 10·61 | 10·23 | 5·21 | 10·56 | 10·19 | 5·21 | 3 |
| 9 | − | − | Cl2 or ClO2 | 4·00 | 4·00 | 4·01 | 0 | 0·21 | 0 | 1 |
| 10 | − | − | Chloramine | 1·01 | 0·13 | 0·03 | 0 | 0·01 | 0 | 1 |
| 11 | − | − | Chemical | 6·01 | 5·63 | 4·11 | 4·43 | 4·01 | 4·01 | 2 |
| 12 | Coag/floc/sed | − | Chemical | 2·56 | 1·68 | 1·79 | 1·86 | 1·62 | 1·62 | 2 |
| 13 | − | RG (no coag)/SS | − | 0·55 | 0·55 | 0·77 | 1·11 | 1·23 | 0·55 | 1 |
| 14 | No treatment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| 15 | Optional coag/floc | MF/UF | Chemical | 5·61 | 4·73 | 1·13 | 6·13 | 6·19 | 1·13 | 2 |
| 16 | − | RG (no coag)/SS and MF/UF | Chemical | 6·16 | 5·28 | 1·90 | 7·24 | 7·42 | 1·90 | 3 |
| 17 | Coag/floc and/or sed/clar | − | Chemical | 6·01 | 5·63 | 4·11 | 4·43 | 4·01 | 4·01 | 2 |
| 18 | − | − | Chemical | 5·01 | 4·13 | 4·03 | 0 | 0·22 | 0 | 2 |
| 19 | ‘Other’ treatment | Treatment that did not fall into any of the above categories | 2·32 | 1 | ||||||
Campy, Campylobacter; clar, clarification; coag, coagulation; Crypto, Cryptosporidium; filt, filtration; floc, flocculation; MF, microfiltration; QMRA, quantitative microbial risk assessment; RG, rapid granular filtration; sed, sedimentation; SS, slow sand filtration; UF, ultrafiltration.
Assumes default values for disinfection contact time (20 min), concentration (0·20 mg/l), temperature (10 °C), pH (6·00), and UV dose (40 mJ/cm2) from Health Canada QMRA model (Health Canada [17]).
For each log reduction value included, and for each pathogen listed, the value listed is the worst-case scenario, for any one of free chlorine, chloramine, ozone, or chlorine dioxide.
Distribution of Canadian population served by surface water and groundwater sources, classified by the dominant form of treatment (membrane filtration, media filtration, chemical disinfection, UV and no treatment)
| Dominant form of treatment | Treatment categories | Population served by surface water | Population served by groundwater |
|---|---|---|---|
| Membrane filtration | 4, 15, 16 | 1 491 579 | 35 803 |
| Media filtration | 1, 2, 3, 13, 19 | 16 044 311 | 336 178 |
| Chemical disinfection | 9, 10, 12, 18 | 1 946 431 | 1 597 615 |
| UV | 5, 6, 7, 8, 11, 17 | 6 393 430 | 236 209 |
| No treatment | 14 | 16 450 | 423 758 |
| Total | 25 892 201 | 2 629 563 | |
Treatment categories correspond with those presented in Table 2.
Population does not include Canadians that report consuming bottled water exclusively for bottled water consumers.
Canadian drinking water distribution system criteria and scores used in the ranking of Canadian distribution systems serving >1000 people
| Criteria | Subcategories | Score |
|---|---|---|
| Pipe material | Metal only | 1 |
| Metal and plastic | 3 | |
| Metal, plastic and other | 5 | |
| Metal and other | 2 | |
| Plastic only | 7 | |
| Plastic and other | 6 | |
| Other only | 4 | |
| Pipe condition state | Sum of very poor and poor, ⩾50% | 1 |
| Sum of good and excellent, ⩾50% | 3 | |
| All other combinations | 2 | |
| System size (pipe length) | Very large, >3000 km | 1 |
| Large, 1001–3000 km | 2 | |
| Medium, 501–1000 km | 3 | |
| Small, <500 km | 4 | |
| Population served | 1000–5000 | 1 |
| >5000–10 000 | 2 | |
| >10 000 | 3 | |
| Storage | Yes | 1 |
| No | 0 | |
| Chloramination | Yes | 0 |
| No | 1 |
Categories based on Folkman [21] and the Canadian Infrastructure Report Card (Supplementary Table S1).
Weightings applied to the drinking water and distribution system criteria used in the ranking of Canadian water systems serving >1000 people
| Weight out of 100 | |
|---|---|
| Drinking water system criteria | |
| Source water type | 10 |
| Source water quality | 30 |
| Log reduction capability of the treatment system | 30 |
| Number of treatment barriers | 20 |
| Population served | 10 |
| Distribution system criteria | |
| Pipe material | 20 |
| Pipe condition | 20 |
| System size (pipe length) | 15 |
| Population served | 15 |
| Storage | 15 |
| Chloramination | 15 |
Summary of randomized controlled household drinking water intervention trials reviewed as potential data sources for estimating the burden of AGI associated with municipal drinking water systems
| Author, publication date, ref. | Use of blinding/ use of an inactive (sham) treatment device | Study population | Study dates | Length of follow-up | Sample size (HH | HCGI incidence due to drinking water | Equivalent AGI |
|---|---|---|---|---|---|---|---|
| Payment | No | General population: homeowners with one child aged 2–12 years (did not exclude immunocompromised individuals) | Jan. 1988– June 1989 | 12 months | 606/2408 | 0·26 cases/p-yr | 0·126 cases/p-yr |
| Payment | No | Sept. 1993– Dec. 1994 | 16 months | 1062/5253 | 0·08 cases/p-yr | 0·0388 cases/p-yr | |
| Hellard | Yes | General population: homeowners with one child aged 2–12 years (excluding those with immunocompromising conditions) | May 2000– May 2001 | 12 months | 714/988 | 0·03 cases/p-yr | 0·0145 cases/p-yr |
| Colford | Yes | Mar. 1999– Oct. 1999 | 4 months | 77/236 | 0·85 cases/p-yr | 0·412 cases/p-yr | |
| Colford | Yes | Oct. 2000– May 2002 | 12 months | 456/1296 | −0·02 cases/p-yr | 0 cases/p-yr | |
| Colford | Yes | HIV + patients, aged >30 years, elderly aged >55 years (excluding immunocompromised individuals) | May 2000– May 2001 | 4 months | ?/50 | 0·70 cases/p-yr | 0·340 cases/p-yr |
| Colford | Yes | Apr. 2001– July 2006 | 12 months | 714/988 | 0·265 cases/p-yr | 0·128 cases/p-yr |
AGI, Acute gastrointestinal illness; HCGI, highly credible gastrointestinal illness; HH, household; p-yr, person-years.
The AGI rates published in the randomized controlled trials (RCTs) were documented in terms of HCGI which is a less restrictive definition of AGI. These HCGI rates were converted to AGI rates using estimated total Canadian HCGI and AGI rates of 1·3 cases/p-yr and 0·63 cases/p-yr, respectively (Thomas et al. [9]). Reported rates from the RCTs were multiplied by 0·63/1·3.
Summary of studies that examine AGI risk associated with drinking water distribution systems (DS)
| Author, date, ref. | Location | Study description/results | Representative of Canada? | Selected | Percentile ranking among Canadian systems |
|---|---|---|---|---|---|
| Nygard | Norway | Study of AGI and DS events; up to 36% of AGI could be due to DS | Not representative: different pipe material and disinfection practices | No | n.a. |
| Lambertini | USA | Risk of DS in untreated groundwater supplies using QMRA; 1–4% of risk could be due to DS | May be representative of some small Canadian rural groundwater systems | No | n.a. |
| Messner | USA/Canada | USA burden estimate: two Payment studies [ | Representative: Payment | Yes | 9·3 |
AGI, Acute gastrointestinal illness; QMRA, quantitative microbial risk assessment.
Mean AGI cases attributable to municipal tap water consumption in Canada attributable to both source water/treatment and the distribution system, and corresponding AGI incidence rates
| Category | Groupings of Canadian systems | Canadian population served by system categories (excluding bottled water) | Mean cases SW/TR (90% CI) | Mean cases DS (90% CI) | Mean total cases (90% CI) | Incidence rate (cases/p-yr) |
|---|---|---|---|---|---|---|
| 1 | Systems that are ⩽16·9 percentile SW/TR; ⩽9·3 percentile DS | 1 069 447 | 30 745 (6436-69 114) | 19 377 (1327-51 541) | 50 121 (13 318-93 879) | 0·047 |
| 2 | Systems that are 17·0–42·9 percentile for SW/TR and ⩽9·3 percentile DS | 2 000 635 | 16 138 (1181-40 621) | 16 138 (1156-40 977) | 32 278 (9869-57 331) | 0·016 |
| 3 | Systems that are 17·0–42·9 percentile for SW/TR and ⩾9·4 percentile DS | 12 780 693 | 135 093 (35 495-277 142) | 71 102 (4988-180 415) | 206 195 (63 047-366 189) | 0·016 |
| 4 | Systems that are ⩾43percentile for SW/TR and ⩾9·4percentile DS | 6 396 200 | 30 382 (9550-59 367) | 15 991 (1267-38 210) | 46 372 (17 541-75 185) | 0·007 |
| Total | 212 358 (101 405-3-0 542) | 122 608 (42 626-236 942) | 334 966 (183 006-501 026) | 0·015 | ||
AGI, Acute gastrointestinal illness; DS, distribution system; SW/TR, source water/treatment.
AGI attributable risk units = cases/person-year.
Fig. 2.Ranking of Canadian municipal drinking water system plant scores including rankings of the systems studied in the randomized controlled trials.
Fig. 3.Ranking of 75 Canadian drinking water distribution system scores including ranking of the system studied by Payment et al. [1, 2].